en · de · es
epitalon-notes.peptides1126.com › Info › Research Claims And Evidence Status — Practical Notes

Research Claims And Evidence Status — Practical Notes

By Editorial Desk · published 2025-07-22 · last reviewed 2025-09-06 · Info

The short version of research chemical fits in a sentence. The long version — which is the one that helps — is below.

Reviewed 2025-09-06. Anything still debated is marked as such rather than presented as settled.

Research Claims and Evidence Status

The most frequently cited laboratory finding is that AEDG increased telomerase activity and extended telomere length in cultured human somatic cells. That work used fetal fibroblast strains and reported changes in enzyme activity alongside altered division counts. Replication by unrelated groups has been limited, and the published record is largely a single-laboratory series rather than a multi-centre programme. The result supports a hypothesis about peptide influence on gene expression in cell culture; it does not by itself establish an effect on telomere length in living animals or in people.

Animal and clinical reports appear mainly in Russian-language journals from the 1990s and 2000s, covering endpoints such as melatonin rhythm, lifespan in aged rodents, and retinal function. Many of these papers involve small groups, lack blinding or placebo comparison, and are difficult to retrieve through indexed databases. Review articles published in English generally summarise the claims without reanalysing the underlying data. Because no large randomised trial exists, the clinical importance of these reported effects stays unresolved and is properly described as an open question.

Identity and Research Background

Epitalon is a synthetic tetrapeptide whose sequence is alanine–glutamate–aspartate–glycine, commonly abbreviated AEDG. It was developed in Russia during the 1980s and 1990s by investigators associated with the St. Petersburg Institute of Bioregulation and Gerontology, who studied short peptides as regulators of gene expression and tissue function. The alternative spelling epithalon appears interchangeably in the literature, and the two names refer to the same molecule. Outside Russia it is encountered chiefly as a research chemical rather than a licensed medicine, and it holds no approval from the United States Food and Drug Administration or the European Medicines Agency.

The peptide is a synthetic analogue of epithalamin, a preparation extracted from bovine pineal glands. Investigators sought a short, chemically defined molecule that would reproduce some of the endocrine and gerontological observations attributed to the glandular extract. Proposed mechanisms centre on induction of telomerase activity, an effect reported in cultured human somatic cells in the early 2000s, together with influences on melatonin secretion and neuroendocrine regulation. Those mechanisms remain incompletely characterised, and the reported telomerase response has not been consistently reproduced by independent groups working in comparable systems.

Epitalon at a glance

PropertyValueNotes
Regulatory statusNot an approved drugMarketed in most countries as a research chemical
Main literature languageRussian and EnglishEarly reports concentrated in Russian journals
Typical stated purity≥95% by HPLCSupplier declaration, seldom independently verified
Principal studied endpointTelomerase activity in vitroMeasured in cultured human cells
Reported administration routesSubcutaneous, intranasalDescribed in exploratory use reports

Stability Handling and Quality Control

Material sold for research use varies widely in documented quality. A useful verification package includes a certificate of analysis that states peptide content rather than only net weight, the chromatographic method and column used, and a mass spectrum consistent with the expected mass. Independent testing by a third-party laboratory is occasionally reported. Statements of identity resting only on a supplier label provide little assurance, and the gap between nominal mass and actual peptide content can be substantial once counterions and residual water are counted.

Peptides of this size are generally stable as dry solids but degrade in solution over time. The principal routes are hydrolysis of the peptide backbone and oxidation, with hydrolysis favoured by elevated temperature and extreme pH. Aqueous solutions held at room temperature can show measurable loss of purity within days, while frozen aliquots are considerably more durable. Because the sequence contains neither cysteine nor methionine, oxidation is less of a concern than for many other peptides, but pH control during handling still matters.

Related pages on this site

Epitalon Background and Discovery

Epitalon is a synthetic four-amino-acid peptide with the sequence alanine-glutamate-aspartate-glycine, commonly abbreviated AEDG. Its molecular formula is C14H22N4O9, and its calculated molar mass is approximately 390.35 grams per mole. The compound is a short fragment related to a peptide fraction isolated from bovine pineal gland extracts, and it is normally supplied as a lyophilised powder intended for laboratory research. It is not a registered pharmaceutical product in most countries.

The peptide emerged from research carried out in Saint Petersburg from the late 1980s onward, where investigators searched for shorter active fragments of a pineal preparation known as epithalamin. The name epitalon was chosen to reflect that parent extract. Early reports described effects on neuroendocrine markers and on the lifespan of laboratory animals. Much of that work appeared in Russian-language journals, with English translations following later, which affects how readily the original protocols can be assessed by outside groups.

Published studies on epitalon are dominated by a small number of research groups, and independent replication in other laboratories remains limited. Proposed mechanisms include activation of telomerase and modulation of melatonin rhythms, but the evidence for either rests mainly on cell cultures and animal models. Whether the peptide produces comparable effects in humans is an open question, and the absence of large controlled trials means the literature is best read as exploratory rather than settled.

Supporting material

== Mechanism of action == After binding to lipopolysaccharide (LPS) in the outer membrane of Gram-negative bacteria, polymyxins disrupt both the outer and inner membranes. The hydrophobic tail is important in causing membrane damage, suggesting a detergent-like mode of action. Removal of the hydrophobic tail of polymyxin B yields polymyxin nonapeptide, which still binds to LPS, but no longer kills the bacterial cell. However, it still detectably increases the permeability of the bacterial cell wall to other antibiotics, indicating that it still causes some degree of membrane disorganization. Gram-negative bacteria can develop resistance to polymyxins through various modifications of the LPS structure that inhibit the binding of polymyxins to LPS. Antibiotic resistance to this drug has been increasing, especially in southern China. Recently the gene mcr-1, which confers the antibiotic resistance, has been isolated from bacterial plasmids in Enterobacteriaceae.

==== Heterozygous ==== MODY is inherited in an autosomal dominant fashion, and most patients therefore have other members of the family with diabetes; penetrance differs between the types (from 40% to 90%).

Histone-arginine N-methyltransferase (EC 2.1.1.125, histone protein methylase I, nuclear protein (histone) N-methyltransferase, protein methylase I, S-adenosyl-L-methionine:histone-arginine omega-N-methyltransferase) is an enzyme with systematic name S-adenosyl-L-methionine:histone-arginine Nomega-methyltransferase. This enzyme catalyses the following chemical reaction

Sources: en.wikipedia.org

Notes from published material

=== Republic of Egypt (from 1953) === King Hussein of Jordan, 1955 Marshal Josip Broz Tito, President of the Federal People's Republic of Yugoslavia, 1956 Prof. Amintore Fanfani, Prime Minister and ad-interim Minister of Foreign Affairs of the Republic of Italy, 1959 Yuri Gagarin, Soviet cosmonaut, 1961 Taha Hussein, Egyptian writer, 1965 Umm kulthum, Egyptian singer and actress, 1965 Mohammed Abdel Wahab, Egyptian singer and composer, 1965 President Jimmy Carter, President of the United States, 1979 Emperor Akihito of Japan Emperor Amha Selassie of Ethiopia Mohammed Burhanuddin, 52nd Da'i al-Mutlaq of the Dawoodi Bohra, 1978 King Bhumibol Adulyadej of Thailand Mohamed ElBaradei, former director general of the International Atomic Energy Agency (IAEA) Queen Elizabeth II, 1975 Birendra Bir Bikram shah Dev, King of Nepal, 1974 Mohammad Reza Pahlavi, Shah of Iran, 1975 Hassaballah El Kafrawy, Egyptian former Minister of Housing Pengiran Anak Haji Mohamed Yusof, prince consort and cheteria of Brunei, 1984 Naguib Mahfouz, Egyptian writer, 1988 King Fahd bin Abdulaziz Al Saud of Saudi Arabia, 1989 Pierre Gemayel, founder of the Lebanese Phalange Emperor Haile Selassie of Ethiopia King Hamad bin Isa Al Khalifa of Bahrain, 2016 King Idris of Libya (Grand Cordon) Ekmeleddin İhsanoğlu, Turkish academic, diplomat and former Secretary-General of the Organisation of Islamic Cooperation (OIC) Émile Lahoud, President of Lebanon, 2000 Makarios III, former president of Cyprus Nelson Mandela, President of South Africa Adly Mansour, former Chief Justice of the Supreme Constitutional Court and former acting President of Egypt King Mohammed VI of Morocco Muhammad Naguib, First President of Egypt Nursultan Nazarbayev, President of Kazakhstan Antonín Novotný, President of Czechoslovakia Sultan Qaboos bin Said al Said of Oman, 1976 Ziaur Rahman, President of Bangladesh Heinrich Rau, East German politician (Grand Cordon), 1961 King Saud bin Abdulaziz Al Saud of Saudi Arabia, 1954 King Norodom Sihanouk of Cambodia William E. Simon, U.S. Secretary of the Treasury Suharto, President of Indonesia Field Marshal Mohamed Hussein Tantawi, former chairman of the Supreme Council of the Armed Forces of Egypt, 2012 Walter Ulbricht, President of East Germany, 1965 George Vasiliou, former president of Cyprus Sir Magdi Habib Yacoub, Egyptian professor of Cardiothoracic Surgery Professor Ahmed Zewail, Egyptian scientist Katerina Sakellaropoulou, President of Greece, 2020 Salva Kiir Mayardit, President of South Sudan, 2020 Haitham bin Tariq, Sultan of Oman, 2023 Narendra Modi, Prime Minister of India, 2023 Mufaddal Saifuddin, 53rd Da'i al-Mutlaq of the Dawoodi Bohras, 2023 Mishal Al-Ahmad Al-Jaber Al-Sabah, Emir of Kuwait, 2024 King Frederik X, King of Denmark, 2024 King Felipe VI, King of Spain, 2025 Donald Trump, President of the United States, 2025

Winged alates mate through nuptial flights in June, but wingless queens and males have a different way of reproduction. During the fall, the wingless queens mate inside the nest. Then, the colony splits and the queen departs with a portion of the colony's workers, in order to start a new colony. The queen must leave the nest, as the workers will try to kill her if she does not. The wingless males mate with the queens while they are still in cocoons, and, unlike Cardiocondyla, do not fight. The males mate with the queens for up to 40 hours, and it is thought that they guard the queens in order to prevent other males from mating with them.

On 18 February 1853, Franz Joseph survived an assassination attempt by Hungarian nationalist János Libényi. The emperor was taking a stroll with one of his officers, Count Maximilian Karl Lamoral O'Donnell, on a city bastion, when Libényi approached him. He immediately struck the emperor from behind with a knife straight at the neck. Franz Joseph almost always wore a uniform, which had a high collar that almost completely enclosed the neck. The collars of uniforms at that time were made from very sturdy material, precisely to counter this kind of attack. Even though the Emperor was wounded and bleeding, the collar saved his life. Count O'Donnell struck Libényi down with his sabre. O'Donnell, hitherto a Count only by virtue of his Irish nobility, was made a Count of the Habsburg monarchy (Reichsgraf). Another witness who happened to be nearby, the butcher Joseph Ettenreich, swiftly overpowered Libényi. For his deed he was later elevated to the nobility by the emperor and became Joseph von Ettenreich. Libényi was subsequently put on trial and condemned to death for attempted regicide. He was executed on the Simmeringer Heide. After this unsuccessful attack, the emperor's brother Archduke Ferdinand Maximilian called upon Europe's royal families for donations to construct a new church on the site of the attack. The church was to be a votive offering for the survival of the emperor. It is located on Ringstraße in the district of Alsergrund close to the University of Vienna, and is known as the Votivkirche.

TrkC (pronounced "Track C"), is apparently the "physiologic" receptor, in that it binds with greatest affinity to NT-3. However, NT-3 is capable of binding and signaling through a TrkC-related receptors called TrkB. Finally, NT-3 also binds a second-receptor type besides Trk receptors, called the LNGFR (for "low affinity nerve growth factor receptor).

Sources: en.wikipedia.org

Frequently asked questions

Has epitalon been studied in people?

Small studies with human participants have been reported, chiefly in Russian-language journals, but they are limited in size and design. No large randomised controlled trial with published results is available.

What is the strongest evidence for its activity?

The most reproducible biochemical observation comes from cultured cells, where the peptide was reported to raise telomerase activity. Whether this translates into measurable health effects in animals or humans is not established.

Why is epitalon sold online?

It is offered as a research chemical for laboratory use, which places it outside the approval pathways applied to medicines. Buyers should expect documentation to differ between suppliers.

What is epitalon?

Epitalon is a synthetic four-amino-acid peptide with the sequence alanine–glutamate–aspartate–glycine, also written AEDG. It was developed in Russian gerontology research and is studied for proposed effects on telomerase, melatonin regulation, and neuroendocrine function. It is not an approved pharmaceutical in the United States or the European Union.

Network